Find a Tender
complete
Official procurement procedure
LSL/MED/0228 Supply of Pfizer Pharmaceutical Products
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: LEIDOS SUPPLY, LIMITED: "LSL/MED/0228 Supply of Pfizer Pharmaceutical Products". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | LEIDOS SUPPLY, LIMITED | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: LEIDOS SUPPLY, LIMITED
Market Analytics
Derived from OCDS awards & bid statistics
Published history for LEIDOS SUPPLY, LIMITED. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
4.9Bids / Report
Supplier ConcentrationModerate Concentration
TSG Associates LLPTop vendor: 27.9% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 17 active published awards; 12 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| TSG Associates LLP | 1 win | £1,900,000 |
| Cooneen Defence Ltd | 1 win | £1,250,000 |
| HTG TRADING LTD | 1 win | £1,120,000 |
| BIO-RAD LABORATORIES LIMITED | 1 win | £1,040,000 |
| Cardioline S.p.A | 1 win | £600,000 |
Procedure terms
Contracting AuthorityLEIDOS SUPPLY, LIMITED | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published28 May 2026, 12:02 BST | Last source update28 May 2026, 12:02 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-06a76d | ||
What is being bought
Leidos Supply Ltd. intends to award a framework agreeement for the provision of Pfizer Solus Pharmaceutical Products for the UK Ministry of Defence. The agreement will be for the duration of 3 years.
Team Leidos/MoD reserve the right to include additional Pfizer Solus products into the agreement that fall within the advertised CPV codes.
The estimated 3-year value is £4,500,000.00 GBP.
What changed
From the official release history
- Status changed to complete
28 May 2026, 12:02 BST - Official notice release published
28 May 2026, 12:02 BST - Buyer information updated
28 May 2026, 12:02 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
28 May 2026, 12:02 BST - Award pending
Not published · £4,500,000
Commercial outcome and competition
Awards Pfizer Ltd £4,500,000 · Not published · pending |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
LEIDOS SUPPLY, LIMITED
Contracting authority GB-COH-09353172Award and contract changes
Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationalePfizer Limited are the exclusive manufacturer for these Pharmaceutical products.
We intend to award to Pfizer Limited under PA 2023
Schedule 5 Paragraphs 5-7 – Direct Award Justifications
The following conditions are met in relation to the public contract— due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required and
(b) there are no reasonable alternatives to those goods, services or works. |